WebFeb 10, 2024 · There is no generic version of Amitiza currently available in the United States. Fraudulent online pharmacies may try to sell you an illegal Amitiza generic, but … WebAMITIZA . Generic Name: Lubiprostonel . Sponsor: Sucampo Pharma Americas, Inc. Approval Date: 11/26/2012 . Indications: Amitiza is a chloride channel activator indicated for: Treatment of chronic idiopathic constipation in adults (1.1) Treatment of irritable bowel syndrome with constipation in women ≥ 18 years old (1.2)
First brand alternative for opioid-induced constipation medication ...
WebJul 8, 2024 · The main ingredient in Amitiza is lubiprostone, a chloride channel activator that stimulates fluid secretion in the gut, leading to more frequent bowel movements. Brand-name Amitiza is manufactured by Takeda Pharmaceuticals, and a generic version containing lubiprostone is also available. WebFeb 1, 2024 · Amitiza; Descriptions. Lubiprostone is used to treat long-lasting constipation in adults. disabled exemption card
Amitiza Prices, Coupons & Savings Tips - GoodRx
WebMay 7, 2024 · The retail cash price of Linzess is $610 per month without insurance. That’s roughly $20 per capsule. For people on long-term therapy, the total cost can cost more than $7,000 per year. There is no generic version of Linzess available. The only other prescription drug that works just like Linzess, Trulance (plecanatide), is also sold ... A generic version of Amitiza has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug … See more Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Medical Disclaimer See more Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims. 1. Method for treating abdominal … See more WebJan 4, 2024 · "This partnership brings the first Amitiza ® generic to patients—giving them a cost-effective alternative," said Jon Holden, Senior Vice President and General Manager, Generics at Endo. "Par is ... disable device security fail